GlaxoSmithKline PLC Director/PDMR Shareholding (8593B)
15 January 2018 - 8:18PM
UK Regulatory
TIDMGSK
RNS Number : 8593B
GlaxoSmithKline PLC
15 January 2018
GlaxoSmithKline plc (the 'Company')
Transaction notification
1. Details of PDMR/person closely associated
with them ('PCA')
=== =========================================================
a) Name Ms E Walmsley
=== ====================== =================================
b) Position/status Chief Executive Officer
=== ====================== =================================
c) Initial notification/ Initial notification
amendment
=== ====================== =================================
2. Details of the issuer, emission allowance
market participant, auction platform, auctioneer
or auction monitor
=== =========================================================
a) Name GlaxoSmithKline plc
=== ====================== =================================
b) LEI 5493000HZTVUYLO1D793
=== ====================== =================================
3. Details of the transaction(s): section
to be repeated for (i) each type of instrument;
(ii) each type of transaction; (iii) each
date; and (iv) each place where transaction(s)
has been conducted
=== =========================================================
a) Description Ordinary shares of 25 pence each
of the financial ('Ordinary Shares')
instrument ISIN: GB0009252882
=== ====================== =================================
b) Nature of Acquisition of Ordinary Shares
the transaction following the re-investment of
dividends paid to shareholders
on 11 January 2018, on shares
held through the Company's Share
Reward Plan.
=== ====================== =================================
c) Price(s) and Price(s) Volume(s)
volume(s) ------------ ----------
GBP13.3087 17
------------ ----------
=== ====================== =================================
d) Aggregated n/a (single transaction)
information
Aggregated
volume Price
=== ====================== =================================
e) Date of the 2018-01-11
transaction
=== ====================== =================================
f) Place of the London Stock Exchange (XLON)
transaction
=== ====================== =================================
1. Details of PDMR/person closely associated
with them ('PCA')
=== =========================================================
a) Name Mr R G Connor
=== ====================== =================================
b) Position/status President, Global Manufacturing
& Supply
=== ====================== =================================
c) Initial notification/ Initial notification
amendment
=== ====================== =================================
2. Details of the issuer, emission allowance
market participant, auction platform, auctioneer
or auction monitor
=== =========================================================
a) Name GlaxoSmithKline plc
=== ====================== =================================
b) LEI 5493000HZTVUYLO1D793
=== ====================== =================================
3. Details of the transaction(s): section
to be repeated for (i) each type of instrument;
(ii) each type of transaction; (iii) each
date; and (iv) each place where transaction(s)
has been conducted
=== =========================================================
a) Description Ordinary shares of 25 pence each
of the financial ('Ordinary Shares')
instrument ISIN: GB0009252882
=== ====================== =================================
b) Nature of Acquisition of Ordinary Shares
the transaction following the re-investment of
dividends paid to shareholders
on 11 January 2018, on shares
held through the Company's Share
Reward Plan.
=== ====================== =================================
c) Price(s) and Price(s) Volume(s)
volume(s) ------------ ----------
GBP13.3087 67
------------ ----------
=== ====================== =================================
d) Aggregated n/a (single transaction)
information
Aggregated
volume Price
=== ====================== =================================
e) Date of the 2018-01-11
transaction
=== ====================== =================================
f) Place of the London Stock Exchange (XLON)
transaction
=== ====================== =================================
1. Details of PDMR/person closely associated
with them ('PCA')
=== =========================================================
a) Name Mr S Dingemans
=== ====================== =================================
b) Position/status Chief Financial Officer
=== ====================== =================================
c) Initial notification/ Initial notification
amendment
=== ====================== =================================
2. Details of the issuer, emission allowance
market participant, auction platform, auctioneer
or auction monitor
=== =========================================================
a) Name GlaxoSmithKline plc
=== ====================== =================================
b) LEI 5493000HZTVUYLO1D793
=== ====================== =================================
3. Details of the transaction(s): section
to be repeated for (i) each type of instrument;
(ii) each type of transaction; (iii) each
date; and (iv) each place where transaction(s)
has been conducted
=== =========================================================
a) Description Ordinary shares of 25 pence each
of the financial ('Ordinary Shares')
instrument ISIN: GB0009252882
=== ====================== =================================
b) Nature of Acquisition of Ordinary Shares
the transaction following the re-investment of
dividends paid to shareholders
on 11 January 2018, on shares
held through the Company's Share
Reward Plan.
=== ====================== =================================
c) Price(s) and Price(s) Volume(s)
volume(s) ------------ ----------
GBP13.3087 23
------------ ----------
=== ====================== =================================
d) Aggregated n/a (single transaction)
information
Aggregated
volume Price
=== ====================== =================================
e) Date of the 2018-01-11
transaction
=== ====================== =================================
f) Place of the London Stock Exchange (XLON)
transaction
=== ====================== =================================
1. Details of PDMR/person closely associated
with them ('PCA')
=== =========================================================
a) Name Mr N Hirons
=== ====================== =================================
b) Position/status SVP, Global Ethics & Compliance
=== ====================== =================================
c) Initial notification/ Initial notification
amendment
=== ====================== =================================
2. Details of the issuer, emission allowance
market participant, auction platform, auctioneer
or auction monitor
=== =========================================================
a) Name GlaxoSmithKline plc
=== ====================== =================================
b) LEI 5493000HZTVUYLO1D793
=== ====================== =================================
3. Details of the transaction(s): section
to be repeated for (i) each type of instrument;
(ii) each type of transaction; (iii) each
date; and (iv) each place where transaction(s)
has been conducted
=== =========================================================
a) Description Ordinary shares of 25 pence each
of the financial ('Ordinary Shares')
instrument ISIN: GB0009252882
=== ====================== =================================
b) Nature of Acquisition of Ordinary Shares
the transaction following the re-investment of
dividends paid to shareholders
on 11 January 2018, on shares
held through the Company's Share
Reward Plan.
=== ====================== =================================
c) Price(s) and Price(s) Volume(s)
volume(s) ------------ ----------
GBP13.3087 10
------------ ----------
=== ====================== =================================
d) Aggregated n/a (single transaction)
information
Aggregated
volume Price
=== ====================== =================================
e) Date of the 2018-01-11
transaction
=== ====================== =================================
f) Place of the London Stock Exchange (XLON)
transaction
=== ====================== =================================
1. Details of PDMR/person closely associated
with them ('PCA')
=== =========================================================
a) Name Mr D S Redfern
=== ====================== =================================
b) Position/status Chief Strategy Officer
=== ====================== =================================
c) Initial notification/ Initial notification
amendment
=== ====================== =================================
2. Details of the issuer, emission allowance
market participant, auction platform, auctioneer
or auction monitor
=== =========================================================
a) Name GlaxoSmithKline plc
=== ====================== =================================
b) LEI 5493000HZTVUYLO1D793
=== ====================== =================================
3. Details of the transaction(s): section
to be repeated for (i) each type of instrument;
(ii) each type of transaction; (iii) each
date; and (iv) each place where transaction(s)
has been conducted
=== =========================================================
a) Description Ordinary shares of 25 pence each
of the financial ('Ordinary Shares')
instrument ISIN: GB0009252882
=== ====================== =================================
b) Nature of Acquisition of Ordinary Shares
the transaction following the re-investment of
dividends paid to shareholders
on 11 January 2018, on shares
held through the Company's Share
Reward Plan.
=== ====================== =================================
c) Price(s) and Price(s) Volume(s)
volume(s) ------------ ----------
GBP13.3087 76
------------ ----------
=== ====================== =================================
d) Aggregated n/a (single transaction)
information
Aggregated
volume Price
=== ====================== =================================
e) Date of the 2018-01-11
transaction
=== ====================== =================================
f) Place of the London Stock Exchange (XLON)
transaction
=== ====================== =================================
1. Details of PDMR/person closely associated
with them ('PCA')
=== =========================================================
a) Name Ms C Thomas
=== ====================== =================================
b) Position/status SVP, Human Resources
=== ====================== =================================
c) Initial notification/ Initial notification
amendment
=== ====================== =================================
2. Details of the issuer, emission allowance
market participant, auction platform, auctioneer
or auction monitor
=== =========================================================
a) Name GlaxoSmithKline plc
=== ====================== =================================
b) LEI 5493000HZTVUYLO1D793
=== ====================== =================================
3. Details of the transaction(s): section
to be repeated for (i) each type of instrument;
(ii) each type of transaction; (iii) each
date; and (iv) each place where transaction(s)
has been conducted
=== =========================================================
a) Description Ordinary shares of 25 pence each
of the financial ('Ordinary Shares')
instrument ISIN: GB0009252882
=== ====================== =================================
b) Nature of Acquisition of Ordinary Shares
the transaction following the re-investment of
dividends paid to shareholders
on 11 January 2018, on shares
held through the Company's Share
Reward Plan.
=== ====================== =================================
c) Price(s) and Price(s) Volume(s)
volume(s) ------------ ----------
GBP13.3087 76
------------ ----------
=== ====================== =================================
d) Aggregated n/a (single transaction)
information
Aggregated
volume Price
=== ====================== =================================
e) Date of the 2018-01-11
transaction
=== ====================== =================================
f) Place of the London Stock Exchange (XLON)
transaction
=== ====================== =================================
1. Details of PDMR/person closely associated
with them ('PCA')
=== =========================================================
a) Name Mr P C Thomson
=== ====================== =================================
b) Position/status President, Global Affairs
=== ====================== =================================
c) Initial notification/ Initial notification
amendment
=== ====================== =================================
2. Details of the issuer, emission allowance
market participant, auction platform, auctioneer
or auction monitor
=== =========================================================
a) Name GlaxoSmithKline plc
=== ====================== =================================
b) LEI 5493000HZTVUYLO1D793
=== ====================== =================================
3. Details of the transaction(s): section
to be repeated for (i) each type of instrument;
(ii) each type of transaction; (iii) each
date; and (iv) each place where transaction(s)
has been conducted
=== =========================================================
a) Description Ordinary shares of 25 pence each
of the financial ('Ordinary Shares')
instrument ISIN: GB0009252882
=== ====================== =================================
b) Nature of Acquisition of Ordinary Shares
the transaction following the re-investment of
dividends paid to shareholders
on 11 January 2018, on shares
held through the Company's Share
Reward Plan.
=== ====================== =================================
c) Price(s) and Price(s) Volume(s)
volume(s) ------------ ----------
GBP13.3087 42
------------ ----------
=== ====================== =================================
d) Aggregated n/a (single transaction)
information
Aggregated
volume Price
=== ====================== =================================
e) Date of the 2018-01-11
transaction
=== ====================== =================================
f) Place of the London Stock Exchange (XLON)
transaction
=== ====================== =================================
1. Details of PDMR/person closely associated
with them ('PCA')
=== =========================================================
a) Name Dr P J T Vallance
=== ====================== =================================
b) Position/status President, R&D
=== ====================== =================================
c) Initial notification/ Initial notification
amendment
=== ====================== =================================
2. Details of the issuer, emission allowance
market participant, auction platform, auctioneer
or auction monitor
=== =========================================================
a) Name GlaxoSmithKline plc
=== ====================== =================================
b) LEI 5493000HZTVUYLO1D793
=== ====================== =================================
3. Details of the transaction(s): section
to be repeated for (i) each type of instrument;
(ii) each type of transaction; (iii) each
date; and (iv) each place where transaction(s)
has been conducted
=== =========================================================
a) Description Ordinary shares of 25 pence each
of the financial ('Ordinary Shares')
instrument ISIN: GB0009252882
=== ====================== =================================
b) Nature of Acquisition of Ordinary Shares
the transaction following the re-investment of
dividends paid to shareholders
on 11 January 2018, on shares
held through the Company's Share
Reward Plan.
=== ====================== =================================
c) Price(s) and Price(s) Volume(s)
volume(s) ------------ ----------
GBP13.3087 47
------------ ----------
=== ====================== =================================
d) Aggregated n/a (single transaction)
information
Aggregated
volume Price
=== ====================== =================================
e) Date of the 2018-01-11
transaction
=== ====================== =================================
f) Place of the London Stock Exchange (XLON)
transaction
=== ====================== =================================
1. Details of PDMR/person closely associated
with them ('PCA')
=== =========================================================
a) Name Mrs V A Whyte
=== ====================== =================================
b) Position/status Company Secretary
=== ====================== =================================
c) Initial notification/ Initial notification
amendment
=== ====================== =================================
2. Details of the issuer, emission allowance
market participant, auction platform, auctioneer
or auction monitor
=== =========================================================
a) Name GlaxoSmithKline plc
=== ====================== =================================
b) LEI 5493000HZTVUYLO1D793
=== ====================== =================================
3. Details of the transaction(s): section
to be repeated for (i) each type of instrument;
(ii) each type of transaction; (iii) each
date; and (iv) each place where transaction(s)
has been conducted
=== =========================================================
a) Description Ordinary shares of 25 pence each
of the financial ('Ordinary Shares')
instrument ISIN: GB0009252882
=== ====================== =================================
b) Nature of Acquisition of Ordinary Shares
the transaction following the re-investment of
dividends paid to shareholders
on 11 January 2018, on shares
held through the Company's Share
Reward Plan.
=== ====================== =================================
c) Price(s) and Price(s) Volume(s)
volume(s) ------------ ----------
GBP13.3087 54
------------ ----------
=== ====================== =================================
d) Aggregated n/a (single transaction)
information
Aggregated
volume Price
=== ====================== =================================
e) Date of the 2018-01-11
transaction
=== ====================== =================================
f) Place of the London Stock Exchange (XLON)
transaction
=== ====================== =================================
This information is provided by RNS
The company news service from the London Stock Exchange
END
DSHKELBFVFFFBBQ
(END) Dow Jones Newswires
January 15, 2018 04:18 ET (09:18 GMT)
Gsk (LSE:GSK)
Historical Stock Chart
From Apr 2024 to May 2024
Gsk (LSE:GSK)
Historical Stock Chart
From May 2023 to May 2024
